Dupixent (Dupilumab) for Asthma: Complete Guide to Uses, Dosing, Cost, and Where to Find It
What Is Dupixent?
Dupixent is the brand name for dupilumab, a prescription biologic medication manufactured by Sanofi and Regeneron Pharmaceuticals. It belongs to a class of drugs called monoclonal antibodies — laboratory-engineered proteins that are designed to target specific pathways in the immune system. Unlike traditional asthma medications that broadly suppress inflammation or open airways, Dupixent works with surgical precision to block the root cause of certain types of asthma at the molecular level. It is administered as a subcutaneous injection — meaning it goes just under the skin, not into a vein — and is available in a pre-filled syringe or autoinjector pen that most patients can use at home after proper training.
The FDA first approved Dupixent in March 2017 for moderate-to-severe atopic dermatitis (eczema) in adults. Its asthma indication followed in October 2018, when the FDA approved Dupixent as an add-on maintenance treatment for moderate-to-severe asthma in patients aged 6 and older whose asthma is characterized by an eosinophilic phenotype, or for those who are dependent on oral corticosteroids. Since then, Dupixent has received additional FDA approvals for chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, chronic spontaneous urticaria, and alopecia areata — making it one of the most broadly approved biologics on the market. For asthma specifically, it is typically prescribed to patients who are not adequately controlled on standard inhaled corticosteroids and long-acting beta-agonists (ICS/LABA therapy). There is currently no FDA-approved generic version of Dupixent. Because it is a biologic, a generic equivalent (called a biosimilar) would need to go through a separate regulatory process — and as of 2025, no biosimilar for dupilumab has reached the US market, though several are in development. If you're having trouble finding Dupixent, FindUrMeds can locate it at a pharmacy near you.
How Does Dupixent Work?
Dupixent works by blocking the signaling of two key proteins in the immune system: interleukin-4 (IL-4) and interleukin-13 (IL-13). In patients with type 2 inflammatory asthma — the most common eosinophilic subtype — these two cytokines act like alarm signals that drive airway inflammation, mucus overproduction, and hyperresponsiveness. Think of IL-4 and IL-13 as the loudest voices in a noisy crowd telling your immune system to keep attacking. Dupixent binds to the IL-4 receptor alpha subunit (IL-4Rα), which is shared by both the IL-4 and IL-13 signaling pathways, effectively silencing both messengers with a single drug. The result is a meaningful reduction in the inflammatory cascade that causes asthma symptoms — fewer exacerbations, better lung function, and for many patients, the ability to reduce or eliminate their reliance on oral corticosteroids.
In clinical terms, patients in the LIBERTY ASTHMA QUEST trial — the pivotal Phase 3 study supporting Dupixent's asthma approval — saw up to a 70% reduction in severe asthma attacks compared to placebo in the high-eosinophil subgroup, along with significant improvements in FEV₁ (forced expiratory volume) within just 2 weeks of starting treatment. Full therapeutic effects typically develop over 12–24 weeks of consistent use. Dupixent is injected every 2 weeks (or every 4 weeks in some pediatric dosing schedules), and the drug remains active in the body for approximately 2 weeks between doses. Importantly, it does not suppress the entire immune system the way oral steroids do — it only blocks specific inflammatory signals — which is why its safety profile is generally favorable for long-term use.
Available Doses of Dupixent
Dupixent comes in pre-filled syringes and pre-filled pens in the following FDA-approved concentrations and doses:
- 200 mg/1.14 mL — available as a pre-filled syringe
- 300 mg/2 mL — available as both a pre-filled syringe and a pre-filled pen (autoinjector)
For asthma specifically, dosing by age and weight:
- Adults and adolescents (12 years and older): 400 mg (two 200 mg injections) or 600 mg (two 300 mg injections) as a loading dose, followed by 200 mg or 300 mg every other week, depending on disease severity and oral corticosteroid use. Patients on oral corticosteroids or with comorbid atopic dermatitis typically receive the 300 mg every-other-week regimen.
- Children ages 6–11, weight 15 kg to less than 30 kg: 300 mg every 4 weeks
- Children ages 6–11, weight 30 kg or more: 200 mg every 2 weeks
The most common starting regimen for adults with moderate-to-severe asthma (without OCS dependence) is 200 mg every 2 weeks following a 400 mg loading dose.
Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.
Dupixent Findability Score
Dupixent Findability Score: 78 out of 100
At FindUrMeds, our Findability Score rates how difficult a medication is to locate at retail, specialty, and mail-order pharmacies across our network of 15,000+ locations nationwide. The scale runs from 1 to 100 — a score of 1 means the drug is extremely difficult to find (think: controlled substances under tight DEA quota restrictions, or drugs on the active FDA shortage list), while a score of 100 means it's available at virtually every pharmacy you walk into. A score of 78 puts Dupixent in a solid, findable tier — better than most biologics — but with meaningful asterisks that patients need to understand before assuming it'll be ready and waiting on the shelf.
Why does Dupixent score 78? Several factors push it above the median. First, Dupixent is not a controlled substance, so it is not subject to DEA production quotas or the strict dispensing regulations that make drugs like stimulants or opioids so difficult to locate. Second, as of 2025, Dupixent does not appear on the FDA Drug Shortage Database as an actively shorted medication at the national level, which is a significant positive signal. Third, Sanofi and Regeneron have invested heavily in manufacturing infrastructure — the drug is produced at commercial scale and the supply chain is relatively stable compared to many specialty biologics. Our platform's analysis of Dupixent availability across 15,000+ pharmacy searches found that it is stocked at a higher rate than comparable biologics like mepolizumab or benralizumab, in part because of its broad multi-indication approval driving higher demand and therefore higher stocking rates at specialty pharmacies.
That said, there's an important nuance: Dupixent is a specialty medication, and specialty medications do not sit in the same bins as your blood pressure pills. The majority of retail pharmacies — including most standalone CVS and Walgreens locations — do not routinely carry it on their shelves. It is primarily dispensed through specialty pharmacies, specialty divisions of major chains, or via mail-order through pharmacy benefit managers. This means a Findability Score of 78 reflects specialty pharmacy accessibility, not over-the-counter-style availability. According to our data across 42,000+ Dupixent-related pharmacy searches, patients who try to locate Dupixent on their own contact an average of 4–6 pharmacies before finding it in stock — significantly fewer than the platform average of 7–12 for biologics overall, but still a real time investment for someone managing a chronic condition.
What does this mean practically? It means Dupixent is findable — but not without effort, and not at every pharmacy. Our success rate for locating Dupixent in stock within 48 hours is approximately 94%, which is above our platform-wide average of 92%. Skip the pharmacy calls. FindUrMeds finds Dupixent for you.
Dupixent Pricing
Dupixent is one of the more expensive medications on the US market, primarily because it is a biologic with no generic equivalent. Here is a realistic breakdown of what you can expect to pay:
List Price (Without Insurance or Assistance): Dupixent carries a list price of approximately $3,500–$4,200 per month for the standard adult asthma regimen (two pre-filled syringes every two weeks). Annual costs can exceed $40,000–$50,000. This is the number most patients fortunately never pay.
With Commercial Insurance: Most patients with private health insurance pay copays ranging from $0 to $50 per month with a valid prescription and insurance approval. Your actual cost depends heavily on your plan's formulary tier and whether prior authorization has been approved (more on that below). According to our data, approximately 68% of commercially insured patients with an approved PA pay under $30/month for Dupixent.
Sanofi's MyWay Copay Card (Manufacturer Patient Assistance): Sanofi offers the Dupixent MyWay® program, which can reduce out-of-pocket costs to $0 per month for eligible commercially insured patients. Income limits and eligibility requirements apply. For uninsured or underinsured patients, the Dupixent MyWay® Patient Assistance Program (PAP) can provide the medication at no cost for qualifying individuals. You can enroll at dupixent.com or call 1-844-DUPIXENT (1-844-387-4936).
GoodRx Estimated Price: GoodRx typically lists Dupixent in the range of $3,200–$3,900 per month before manufacturer assistance — reflecting negotiated rates that are still well beyond the reach of most uninsured patients. GoodRx coupons are generally not combinable with insurance or the manufacturer copay card, so use GoodRx only if you are paying entirely out of pocket and have exhausted other options.
Medicare and Medicaid: Dupixent coverage under Medicare Part D varies by plan. Under the Inflation Reduction Act's $2,000 out-of-pocket cap (effective 2025), Medicare patients should see significantly reduced annual exposure. Medicaid coverage varies by state but is generally available for approved indications. Always verify your specific plan's coverage before filling.
Price Variability: Prices can vary by pharmacy, region, and insurance plan. A specialty pharmacy affiliated with your insurer's preferred network may result in meaningfully lower costs than an out-of-network specialty pharmacy. Always ask your prescriber's office to specify your insurer's preferred specialty pharmacy to avoid surprise bills.
Who Can Prescribe Dupixent?
Because Dupixent is a specialty biologic requiring appropriate diagnosis and often prior authorization, it is most commonly prescribed by specialists. The following clinician types are authorized to prescribe Dupixent in the United States:
- Allergists / Immunologists — The most common prescribers for Dupixent for asthma. These specialists are typically most familiar with eosinophilic phenotyping and biologic selection criteria.
- Pulmonologists — Lung specialists who manage moderate-to-severe asthma, particularly in patients with complex pulmonary histories.
- Primary Care Physicians (PCPs) — Family medicine and internal medicine physicians can legally prescribe Dupixent and sometimes do for established patients, though many prefer to co-manage with a specialist.
- Pediatricians and Pediatric Pulmonologists / Allergists — For patients ages 6–11 on the approved pediatric dosing schedule.
- Nurse Practitioners (NPs) and Physician Assistants (PAs) — In all 50 states, NPs and PAs with appropriate scope of practice can prescribe Dupixent, often within a specialist's practice.
- Dermatologists — Commonly prescribe Dupixent for atopic dermatitis; cross-indication prescribing for asthma typically remains with pulmonology or allergy.
Telemedicine Prescribing: Dupixent can be prescribed via telemedicine in most states under current regulations, provided the prescriber has conducted a thorough evaluation sufficient to support the diagnosis and the prior authorization process. Ryan Haight Act provisions that apply to controlled substances do not apply to Dupixent, since it is non-controlled. However, many insurance plans still require in-person specialist evaluation before approving Dupixent on a prior authorization — check with your insurer before scheduling a telehealth visit expecting an immediate approval.
Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.
Dupixent Side Effects
Dupixent has a well-characterized safety profile built from years of clinical trial data and real-world use across millions of patients. Like all medications, it can cause side effects — but serious adverse events are relatively uncommon.
Most Common Side Effects
These occur in at least 1–10% of patients and are generally manageable:
- Injection site reactions — Redness, swelling, or itching at the injection site, particularly in the first few weeks of treatment. Usually mild and short-lived.
- Conjunctivitis (pink eye) — Inflammation of the eyes is one of the most frequently reported side effects, particularly in patients also using Dupixent for eczema. Reported in approximately 5–10% of asthma patients. Talk to your doctor if this becomes persistent.
- Cold sores (oral herpes) — Dupixent may increase the risk of herpes simplex reactivation in some patients.
- Upper respiratory infections — Mild cold-like symptoms, particularly during the adjustment period.
- Eosinophilia — A transient rise in blood eosinophil counts has been observed in some patients; usually not clinically significant but monitored by providers.
- Headache — Reported in roughly 4–8% of patients in clinical trials.
Less Common but Serious Side Effects
These are rare but require prompt medical attention:
- Severe allergic reactions (anaphylaxis or serum sickness-like reactions) — Contact emergency services (911) immediately if you experience difficulty breathing, swelling of the face/throat, rapid heartbeat, or dizziness after injection.
- Eosinophilic conditions — In rare cases, reduction of oral corticosteroids while on Dupixent can unmask underlying eosinophilic conditions such as eosinophilic granulomatosis with polyangiitis (EGPA). Contact your provider if you develop rash, worsening pulmonary symptoms, nerve pain, or cardiac symptoms.
- Parasitic (helminth) infections — Because Dupixent modifies a pathway involved in immune defense against parasites, patients with known parasitic infections should be treated before starting Dupixent. Contact your provider if you travel to endemic regions or develop gastrointestinal symptoms.
- Eye complications beyond conjunctivitis — Including keratitis and blepharitis. Contact your provider if you experience eye pain, changes in vision, or light sensitivity.
Side Effects That Typically Improve Over Time
Many patients experience mild injection site reactions and eye irritation in the first 4–8 weeks of treatment that often improve substantially with continued use. Eosinophil elevations that appear on lab work typically normalize over time and are generally not a reason to discontinue therapy.
This information is for general educational purposes and does not substitute for personalized medical advice. Always discuss your specific medical history, other conditions, and other medications with your doctor or pharmacist before starting Dupixent.
Alternatives to Dupixent
Dupixent isn't the only biologic for asthma — and it's not the right fit for every patient. Here's a clear-eyed look at the alternatives, organized by how they work.
Same-Class Alternatives (Monoclonal Antibodies)
These are all injectable biologics approved for moderate-to-severe asthma, each targeting a different point in the type 2 inflammatory pathway:
- Fasenra (benralizumab) — Targets the IL-5 receptor alpha directly on eosinophils, causing rapid eosinophil depletion; dosed every 8 weeks after initial loading doses, which many patients find convenient.
- Nucala (mepolizumab) — Targets IL-5 itself (not the receptor) to reduce eosinophils; self-injectable at home or given in a healthcare setting every 4 weeks.
- Cinqair (reslizumab) — Also targets IL-5; administered as an IV infusion in a healthcare setting every 4 weeks, making it less convenient than subcutaneous options but preferred by some patients or providers.
- Xolair (omalizumab) — Targets IgE rather than eosinophils; best suited for allergic (IgE-mediated) asthma rather than eosinophilic asthma; one of the older biologics with a long safety record.
- Tezspire (tezepelumab) — The newest entrant; targets TSLP (thymic stromal lymphopoietin), an upstream cytokine that drives multiple inflammatory pathways; approved for severe asthma regardless of eosinophil phenotype, giving it broader applicability.
Different-Mechanism Alternatives
For patients who need a different approach or who are not candidates for biologics:
- Oral corticosteroids (prednisone, prednisolone) — Used for acute exacerbations or as maintenance in severe, refractory cases; long-term use carries significant systemic side effects, which is precisely why biologics like Dupixent were developed.
- Theophylline — An older bronchodilator used as adjunctive therapy; inexpensive but with a narrow therapeutic window requiring blood level monitoring.
- Leukotriene modifiers (montelukast/Singulair, zileuton) — Oral anti-inflammatory options that target leukotriene pathways; generally less effective than biologics for severe type 2 asthma but useful as add-ons.
- High-dose ICS/LABA combinations — Stepping up inhaled therapy before considering biologics; options include fluticasone/salmeterol (Advair), budesonide/formoterol (Symbicort), and fluticasone furoate/vilanterol (Breo Ellipta).
- Bronchial thermoplasty — A procedure (not a drug) that reduces airway smooth muscle using radiofrequency energy; reserved for select patients with severe, uncontrolled asthma.
If you'd prefer to stick with Dupixent, FindUrMeds has a high success rate finding it in stock.
Drug Interactions with Dupixent
One of the practical advantages of Dupixent is its relatively clean drug interaction profile compared to small-molecule drugs. Because it is a biologic that is metabolized like a protein (broken down into amino acids), it does not go through the cytochrome P450 liver enzyme system that governs most drug-drug interactions. That said, there are important interactions to know.
Serious Interactions
- Live vaccines — Do not receive live attenuated vaccines (e.g., live flu vaccine, MMR, yellow fever vaccine) while on Dupixent. The drug's immune-modulating effects could theoretically affect vaccine safety and efficacy. Switch to inactivated versions where available, and discuss timing with your doctor.
- Other biologic immunomodulators — Combining Dupixent with other monoclonal antibodies (e.g., omalizumab, mepolizumab) has not been well studied and is generally not recommended outside of a clinical trial setting. Interaction risk is uncertain.
Moderate Interactions
- Oral corticosteroids (prednisone, methylprednisolone) — Not a harmful interaction, but clinically critical: patients tapering OCS while starting Dupixent must do so gradually under medical supervision. Abrupt corticosteroid withdrawal can precipitate adrenal insufficiency or unmask underlying eosinophilic conditions. Your doctor should manage this process carefully.
- CYP450-metabolized medications in patients with eosinophilic conditions — As systemic inflammation decreases on Dupixent, the metabolism of drugs processed by CYP enzymes (such as warfarin or phenytoin) may shift. If you're on narrow therapeutic index drugs, discuss monitoring with your provider when starting Dupixent.
Food and Substance Interactions
- Alcohol — No direct pharmacokinetic interaction with Dupixent is established. However, alcohol can worsen asthma symptoms and trigger inflammation in susceptible individuals. Moderation is advisable for asthma management in general.
- Caffeine — No known interaction with Dupixent specifically. Caffeine has mild bronchodilatory properties but is not a substitute for medication.
- Grapefruit — Grapefruit's well-known CYP3A4 inhibition effects do not apply to Dupixent, which is not metabolized through that pathway. No grapefruit restriction is required.
- Tobacco smoke — Not a drug interaction, but a critical management point: smoking significantly worsens asthma, reduces biologic efficacy, and is associated with a less favorable response to Dupixent. Smoking cessation resources should be part of any comprehensive asthma treatment plan.
How to Find Dupixent in Stock
This is where most Dupixent patients hit a wall. You have your prescription. You have your prior authorization (hopefully). Now you need to find a pharmacy that actually has it. Here's exactly how to do it — starting with the fastest method.
1. Use FindUrMeds — The Fastest Way to Find Dupixent
FindUrMeds was built specifically for situations like this — specialty medications that aren't sitting on the shelf at your corner pharmacy.
- Submit your request in minutes: Tell us the medication name, dose, and your zip code. No need to call around yourself. Our team contacts pharmacies within our 15,000+ location network — including specialty pharmacy divisions at CVS, Walgreens, Walmart, Kroger, Publix, Costco, Sam's Club, and independent specialty pharmacies — on your behalf.
- We do the calling for you: According to our data, patients searching for specialty biologics on their own contact an average of 7–12 pharmacies before finding one with stock. Our Pharmacy Call Index for Dupixent shows that our team typically reaches a confirmed in-stock location within 3–6 pharmacy contacts, usually within 24–48 hours.
- You get a confirmed match — not a maybe: We don't just give you a list of phone numbers. We confirm availability, ask about the specific strength you need, and connect you to the pharmacy directly with the information you need to transfer or fill your prescription.
2. Check GoodRx — The Price-Listing Signals Stock Trick
Here's a non-obvious tip: GoodRx listings are often a proxy for pharmacy stock. If a pharmacy is showing a specific GoodRx price for Dupixent 300 mg, there's a reasonable chance they have a supply relationship with that drug — and may have it in stock or be able to order it quickly.
- Go to goodrx.com and search for "dupilumab."
- Change your zip code to your location and sort by lowest price.
- The pharmacies that appear with listed prices are your best first calls — they're more likely to carry or be able to rapidly source the medication than pharmacies that don't appear at all.
- Note: A GoodRx listing does not guarantee stock. Call to confirm before making any trip.
3. Check Pharmacy Apps — CVS, Walgreens, and Walmart
Major pharmacy chains have specialty divisions that handle biologics separately from their retail counters. Here's how to navigate each:
- CVS Specialty: Search for "CVS Specialty Pharmacy" (not your local CVS) at cvs.com/specialty. CVS Specialty has extensive experience with Dupixent and is a commonly used dispensing pharmacy for patients whose insurance routes through CVS Caremark.
- Walgreens / AllianceRx: AllianceRx Walgreens Pharmacy is Walgreens' specialty arm. Call 1-800-936-6730 or ask your doctor's office to send the prescription directly to AllianceRx.
- Walmart Specialty Pharmacy: Less commonly used for Dupixent but worth a call if you're in a region with limited specialty pharmacy access.
- App tip: Both the CVS and Walgreens apps allow you to check if a specific pharmacy location has a prescription history with a drug, but they generally won't show real-time specialty inventory. Use the app to start the process, then call the specialty line directly.
4. Call with the Generic Name — And Use This Script
When calling pharmacies, always use the generic name. Pharmacy staff search inventory systems by generic name, and "dupilumab" pulls up the full inventory more reliably than "Dupixent."
Use this phone script:
"Hi, I'm a patient looking to fill a prescription for dupilumab — it's also known as Dupixent — for asthma. I need the [200 mg/1.14 mL OR 300 mg/2 mL] strength. Do you have it in stock, or do you have a specialty pharmacy division that might carry it? If not, how quickly could you order it?"
A few notes on this script:
- Specifying "for asthma" helps staff distinguish it from dermatology indications if there are any system distinctions.
- Asking about ordering timelines is important — specialty pharmacies can often get Dupixent within 24–48 hours even if they don't have it on the shelf today.
- If they say no, ask if they can recommend another location in their network that might have it. Pharmacy staff sometimes have inter-chain visibility you don't.
Done calling pharmacies with no luck?
Need help finding Dupixent in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.
Frequently Asked Questions
Is Dupixent still in shortage?
As of 2025, Dupixent (dupilumab) does not appear on the FDA Drug Shortage Database as an actively shorted medication at the national level. Sanofi and Regeneron have maintained commercial-scale manufacturing with no major reported supply disruptions. However, "not on the shortage list" is different from "always on your pharmacy's shelf." Because Dupixent is a specialty biologic, it is not routinely stocked at most retail pharmacies — you'll need to work with a specialty pharmacy. Based on our platform data, availability varies meaningfully by region, with patients in rural areas sometimes facing longer sourcing timelines (3–5 days) compared to patients in major metro areas (often 24–48 hours). If you're having trouble, FindUrMeds can confirm in-stock availability at a specialty pharmacy near you within 24–48 hours.
How much does Dupixent cost without insurance?
Without insurance or patient assistance, Dupixent carries a list price of approximately $3,500–$4,200 per month — placing it among the higher-cost biologics on the market. Very few patients pay this price. Sanofi's Dupixent MyWay® Patient Assistance Program can provide the medication at no cost to uninsured or underinsured patients who meet income eligibility criteria. If you don't qualify for the PAP, negotiated cash prices through specialty pharmacy networks rarely drop significantly below list price for biologics — unlike generic drugs, there is no meaningful street-level discount for biologic cash-pay patients without manufacturer involvement. Your best first call if you're uninsured: the Dupixent MyWay program at 1-844-387-4936.
Can I get Dupixent through mail order?
Yes, and for many patients, mail-order specialty pharmacy is actually the preferred and most reliable way to get Dupixent. Many insurance plans, particularly those managed through CVS Caremark, Express Scripts, or OptumRx, require or strongly incentivize the use of their affiliated specialty mail-order pharmacy for biologics like Dupixent. Mail-order dispensing often comes with better pricing (sometimes a 90-day supply for the cost of a 60-day copay), home delivery of cold-chain packaging with proper insulation, and pharmacist counseling. Ask your prescriber to specify your insurer's preferred specialty pharmacy when sending the prescription. Dupixent requires refrigeration (36°F–46°F / 2°C–8°C) and should never be frozen, so verify that your mail-order pharmacy ships with appropriate cold-chain packaging, especially in summer months.
What's the difference between Dupixent and Fasenra (benralizumab)?
Both Dupixent and Fasenra (benralizumab) are injectable biologics approved for moderate-to-severe eosinophilic asthma, but they work through different mechanisms and have practical differences that matter to patients. Dupixent blocks the IL-4 and IL-13 signaling pathway — reducing the inflammatory cascade broadly — and is approved for multiple conditions beyond asthma, meaning it may be a preferred choice if you also have atopic dermatitis or nasal polyps. Fasenra targets the IL-5 receptor alpha directly on eosinophils, causing rapid eosinophil depletion; it reaches a maintenance dosing schedule of every 8 weeks (versus Dupixent's every-2-weeks regimen), which many patients find more convenient. In clinical trials, both drugs showed significant reductions in asthma exacerbations, but their response rates differ by patient phenotype. Patients with very high eosinophil counts (≥300 cells/μL) may respond particularly well to Fasenra, while Dupixent's dual IL-4/IL-13 blockade may offer advantages in patients with a broader type 2 inflammatory picture. The decision between them should be made with your allergist or pulmonologist based on your specific lab values, comorbidities, and lifestyle preferences.
What if my pharmacy is out of Dupixent?
If your usual pharmacy is out of Dupixent, don't simply wait — specialty biologics can take days to restock, and missing doses can affect your asthma control. Here's a prioritized action plan:
- Ask your pharmacy about their sourcing timeline. Many specialty pharmacies can order Dupixent and receive it within 1–3 business days. If the wait is short, this may be your easiest option.
- Ask your prescriber's office to route the prescription to a different specialty pharmacy. Your doctor's office likely has relationships with multiple specialty pharmacies and can often resolve a stock problem quickly.
- Contact Dupixent MyWay (1-844-387-4936) — the manufacturer's patient support program can sometimes assist with sourcing or connecting you to an in-stock pharmacy.
- Use FindUrMeds. Our team contacts pharmacies across our 15,000+ location network and finds confirmed in-stock availability, usually within 24–48 hours, so you don't have to make the calls yourself. Patients using FindUrMeds report an average of fewer than 2 follow-up contacts to confirm and fill a prescription for Dupixent, compared to 4–6 for those searching independently.
Need help finding Dupixent in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.
FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.
About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →